Bioresorbable Implants Market Analysis and Forecast (2024-2031)

Bioresorbable Implants Market Size

The bioresorbable implants market was valued at 7,389.9 USD million in 2023 and is projected to reach YY USD million by 2031, growing at a compound annual growth rate (CAGR) of 7.40% from 2024 to 2031.

Bioabsorbable implants are designed to gradually dissolve within the body, eliminating the need for a second surgery to remove synthetic materials. These implants, made from both synthetic and natural materials, serve a variety of medical purposes, including ocular implants and bone graft fixations.

According to DataM Intelligence, the bioresorbable implants market analysis provides a comprehensive view of the market, integrating both quantitative and qualitative data. The report includes market size, growth trends, opportunities, and forecasts up to 2031 for key countries such as the United States, Canada, Brazil, Germany, Italy, Spain, the United Kingdom, Russia, the UAE, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and others.

Download free Sample: https://www.datamintelligence.com/download-sample/bioresorbable-implants-market

The North American region is expected to dominate the global market throughout the forecast period, with the United States and Canada contributing the largest share. The European market is also projected to maintain a significant presence globally during 2024-2031.

Bioresorbable Implants Market Dynamics
Key players in the market are focusing on obtaining FDA approvals to drive market growth.

Several bioresorbable implants have recently emerged as viable alternatives for various medical conditions. These implants dissolve in the body and are replaced by natural bone. Larger implants require an interconnected porous structure for better vascularization, which can be manufactured directly using additive manufacturing technology. Leading market competitors are actively seeking FDA clearance for innovative products to treat patients. For instance, Boston Scientific launched its SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System, which has gained global acceptance for its healing properties and suitability for complex cases. Additionally, Bioretec Ltd. received FDA breakthrough device designation for its RemeOs Screws, designed for orthopedic surgery. These screws, made from a bioactive alloy containing magnesium, zinc, and calcium, promote new bone formation. Similarly, the Durysta (bimatoprost implant) received FDA approval in March 2020 for treating open-angle glaucoma or ocular hypertension, releasing medication directly into the eye over time.

View Full Report: https://www.datamintelligence.com/research-report/bioresorbable-implants-market

Market Restraints
Factors such as high system maintenance costs, fears of losing control over outsourced processes, data security concerns, and rapid economic changes are expected to hinder market growth during the forecast period.

Industry Analysis
The bioresorbable implants market offers an in-depth analysis based on various industry factors, including unmet needs, pricing, supply chain dynamics, and regulatory considerations.

COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global bioabsorbable implants market. The strain on healthcare systems led to the postponement of elective surgeries, including orthopedic procedures, reducing the demand for bioresorbable implants. Supply chain disruptions and raw material shortages also constrained market growth. Despite these challenges, the market is expected to recover and grow significantly in the coming years.

Market Segmentation

• By Material Type
o Metallic*
o Polymers
o PLGA- Polylactic-co-glycolic acid
o PLLA- Poly L-lactide
o PGA- Polyglycolic Acid
o PLA- Polylactic Acid
o Others
• By Application
o Cardiovascular*
o Orthopedics
o Others
• By End-User
o Hospitals*
o Ambulatory Surgical Centers
o Others

Geographical Share
The North American region is projected to hold the largest share of the global bioresorbable implants market.

North America's dominance is attributed to the high prevalence of cardiovascular diseases and an aging population, leading to increased cases of osteoporosis and osteoarthritis. Technological advancements in bioabsorbable implants and the approval of new products by the FDA further drive market growth. For instance, Stryker's SonicAnchor uses ultrasonic energy for secure tissue fixation, while Northwestern University developed a flexible bioabsorbable implant for pain relief.

Key Players
Major players in the bioresorbable implants market include Bioretec Ltd., Stryker Corporation, ConMed Corporation, Syntellix AG, Johnson & Johnson, Zimmer Biomet, Becton Dickinson and Company, KLS Martin, Smith and Nephew, and Evonik Industries AG.

Bioretec Ltd. Overview
Bioretec Ltd. specializes in developing bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products, compliant with ISO 13485:2016 and FDA regulations, are used worldwide. Their RemeOs bioresorbable magnesium implants, currently in clinical testing, offer a robust solution for load-bearing medical operations, eliminating the need for implant removal while maintaining strength and rigidity comparable to traditional steel or titanium implants.

Relate Report:
https://www.datamintelligence.com/research-report/dental-implants-market
https://www.datamintelligence.com/research-report/corneal-implants-market
https://www.datamintelligence.com/research-report/medical-implants-market

Company Name: DataM Intelligence
Contact Person: Sai.K
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website:https://www.datamintelligence.com/

DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.